BML Inc. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
99,047
104,404
109,024
111,243
113,502
117,129
Cost of Goods Sold (COGS) incl. D&A
62,605
67,365
70,169
71,443
73,038
74,901
Gross Income
36,442
37,039
38,855
39,800
40,464
42,228
SG&A Expense
16,615
17,039
17,100
30,470
31,126
31,777
EBIT
19,827
20,000
21,755
9,330
9,338
10,451
Unusual Expense
59
323
4
126
5
4
Non Operating Income/Expense
385
498
431
351
479
434
Interest Expense
64
56
48
41
39
37
Pretax Income
8,568
7,179
8,808
9,514
9,774
10,844
Income Tax
3,220
2,967
2,958
3,113
3,345
3,703
Consolidated Net Income
5,348
4,212
5,850
6,401
6,429
7,141
Net Income
4,990
3,874
5,424
5,949
5,989
6,647
Net Income After Extraordinaries
4,990
3,874
5,424
5,949
5,989
6,647
Net Income Available to Common
4,990
3,874
5,424
5,948
5,988
6,646
EPS (Basic)
117.49
91.21
127.69
140.01
140.81
156.05
Basic Shares Outstanding
42
42
42
42
43
43
EPS (Diluted)
117.13
90.91
127.26
139.53
140.42
155.81
Diluted Shares Outstanding
43
43
43
43
43
43
EBITDA
25,317
25,979
27,518
14,490
14,669
15,783
Minority Interest Expense
358
338
426
452
440
494

About BML

View Profile
Address
5-21-3 Sendagaya
Tokyo Tokyo 151
Japan
Employees -
Website http://www.bml.co.jp
Updated 07/08/2019
BML, Inc. engages in the clinical and medical laboratory testing services for hospitals and clinics. It operates through the Clinical Testing and Medical Information Systems segments. The Clinical Testing segment provides laboratory testing, frontier and symphony systems, and preventive medicine.